Abstract
The PRL response to iv cimetidine was tested in 8 healthy males and 8 females at 4 different dose levels (0.75, 1.5, 3.0 and 6.0 mg/kg bw). Serum PRL levels were significantly increased in comparison with a placebo study by the second cimetidine dose in both sexes. The PRL response was significantly higher in females than in males at all but the lowest dose tested. A significant correlation between the cimetidine dose and the PRL response was observed. There were no significant modifications in serum GH, LH, FSH, IRI and glucose. Present findings demonstrate that the stimulation of PRL release by iv cimetidine is quite specific and dose-dependent.
References
Kruss D.M., Littman A. Safety of cimetidine. Gastroenterology 74: 478, 1978.
Carlson H.E., Ippoliti A.F. Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab. 45: 367, 1977.
Burland W.L., Gleadle R.I., Lee R.M., Rowley-Jones D. Prolactin responses to cimetidine. Br. J. Clin. Pharmacol. 7: 19, 1979.
Daubresse J.C., Meunier J.C., Ligny G. Plasma prolactin and cimetidine. Lancet 1: 99, 1978.
Noel G.L., Suh H.K., Stone J.G., Frantz A.G. Human prolactin and growth hormone release during surgery and other conditions of stress. J. Clin. Endocrinol. Metab. 35: 840, 1972.
Jacobs L.S., Snyder P.J., Utiger R.D., Daughaday W.H. Prolactin response to thyrotropin-releasing hormone in normal subjects. J. Clin. Endocrinol. Metab. 37: 1069, 1973.
Buckman M.T., Peake G.T. Estrogen potentiation of phenothiazine-induced prolactin secretion in man. J. Clin. Endocrinol. Metab. 37: 977, 1973.
Mancini A.M., Guitelman A., Vargas C.A., Debeljuk L., Aparicio N.J. Effect of sulpiride on serum prolactin levels in humans. J. Clin. Endocrinol. Metab. 42: 181, 1976.
Judd S.J., Lazarus L., Smythe G. Prolactin secretion by metoclopramide in man. J. Clin. Endocrinol. Metab. 43: 313, 1976.
Carlson H.E., Jacobs L.S., Daughaday W.H. Growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment. J. Clin. Endocrinol. Metab. 37: 488, 1973.
Sharpe P.G., Hawkins B.W. Efficacy and safety of cimetidine. Long term treatment with cimetidine. In: Burland W.L., Simkins M.A. (Eds.), Cimetidine Proceedings of the Second International Symposium on Histamine H2-Receptor Antagonists. Excerpta Medica, Amsterdam, 1977, p. 358.
Regan P.T., Malagelada J.-R., Dimagno E.P., Go V.L.W. Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin. Proc. 53: 79, 1978.
Jefferys D.B., Vale J.A. Effect of cimetidine on glucose handling. Lancet 1: 383, 1978.
Bateson M.C., Browning M.C.K., Maconnachie A. Galactorrhoea with cimetidine. Lancet 2: 247, 1977.
Delle Fave G.F., Tamburrano G., De Magistris L., Natoli C., Santoro M.L., Carratù R., Torsoli A. Variations in serum prolactin following cimetidine treatment for peptic ulcer disease. Rendic. Gastroenterol. 9: 142, 1977.
Petrillo M., Prada A., Bianchi Porro G., Bevilacqua M., Raggi V., Norbiato G. Plasma-prolactin and cimetidine. Lancet 2: 761, 1977.
Majumdar S.K., Thomson A.D., Shaw G.E. Cimetidine and serum prolactin. Br. Med. J. 1: 409, 1978.
Spiegel A.M., Lopatin R., Peikin S., Mc Carthy D. Serum-prolactin in patients receiving chronic oral cimetidine. Lancet 7: 881, 1978.
Arakelian M.C., Libertun C. H1 and H2 histamine receptor participation in the brain control of prolactin secretion in lactating rats. Endocrinology 100: 890, 1977.
Libertun C., Mc Cann S.M. The possible role of histamine in the control of prolactin and gonadotropin release. Neuroendocrinology 20: 110, 1976.
Rivier C., Vale W. Effects of γ-aminobutyric acid and histamine on prolactin secretion in the rat. Endocrinology 101: 506, 1977.
Pontiroli A.E., Pozza G. Histamine stimulates prolactin release in normal men. Acta Endocrinol. (Kbh.) 88: 23, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caldara, R., Bierti, L., Barbieri, C. et al. Stimulation of prolactin release by intravenous cimetidine: a dose-response study. J Endocrinol Invest 2, 79–81 (1979). https://doi.org/10.1007/BF03349280
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349280